marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
Karyopharm Therapeutics Balance Sheet 2011-2024 | KPTI
Annual Balance Sheet Karyopharm Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-46.1 M | -126 M | -179 M | 33.9 M | 114 M | 195 M | -69 M | -49.7 M | -58.4 M | -151 M | -156 M | -391 K | -6.51 M |
Long Term Debt |
2.79 M | 6.1 M | 8.97 M | 118 M | 110 M | 103 M | - | - | - | - | - | - | - |
Long Term Debt Current |
3.31 M | 2.87 M | 2.32 M | 1.92 M | 1.65 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 199 M | 111 M | 1.36 M | 1.67 M | 1.95 M | 1.24 M | - | 27.3 M | 17.8 M |
Total Current Liabilities |
69.5 M | 65.9 M | 73.7 M | 60.2 M | 46.4 M | 46.9 M | 49.5 M | 16.5 M | 15.1 M | 12.3 M | 3.29 M | - | - |
Total Liabilities |
377 M | 375 M | 385 M | 263 M | 245 M | 158 M | 50.8 M | 18.1 M | 17.1 M | 13.5 M | 3.29 M | 29.2 M | 19.9 M |
Deferred Revenue |
- | - | - | - | 2.34 M | 9.36 M | 21.9 M | - | - | - | 79 K | 66 K | 200 K |
Retained Earnings |
-1.49 B | -1.34 B | -1.18 B | -1.07 B | -873 M | -674 M | -495 M | -366 M | -257 M | -138 M | -62.6 M | -28.6 M | -12.7 M |
Total Assets |
240 M | 358 M | 305 M | 313 M | 295 M | 341 M | 180 M | 180 M | 215 M | 220 M | 158 M | 1.31 M | 7.22 M |
Cash and Cash Equivalents |
52.2 M | 135 M | 190 M | 85.9 M | 129 M | 118 M | 69 M | 49.7 M | 58.4 M | 151 M | 156 M | 391 K | 6.51 M |
Book Value |
-136 M | -16.7 M | -79.7 M | 50.5 M | 49.8 M | 183 M | 129 M | 162 M | 198 M | 207 M | 155 M | -27.9 M | -12.7 M |
Total Shareholders Equity |
-136 M | -16.7 M | -79.7 M | 50.5 M | 49.8 M | 183 M | 129 M | 162 M | 198 M | 207 M | 155 M | -27.9 M | -12.7 M |
All numbers in USD currency
Quarterly Balance Sheet Karyopharm Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 955 K | 1.88 M | 2.79 M | 3.67 M | 4.5 M | 5.31 M | 6.1 M | 6.86 M | - | 8.29 M | 8.97 M | 9.63 M | 10.2 M | 10.7 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
349 M | 346 M | 373 M | 377 M | 370 M | 369 M | 371 M | 375 M | 372 M | - | 377 M | 385 M | 380 M | 370 M | 315 M | 263 M | 263 M | 263 M | 263 M | 245 M | 245 M | 245 M | 245 M | 158 M | 158 M | 158 M | 158 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 3.29 M | 3.29 M | 3.29 M | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 297 K | 297 K | 297 K | 297 K | 2.34 M | 2.34 M | 2.34 M | 2.34 M | 9.36 M | 9.36 M | 9.36 M | 9.36 M | 21.9 M | 21.9 M | 21.9 M | 21.9 M | - | - | - | - | - | - | - | - | - | 14 K | 36 K | 57 K | 79 K | 79 K | 79 K | 79 K | 66 K | 66 K | - | - | - | - | - | - |
Retained Earnings |
-1.53 B | -1.5 B | -1.52 B | -1.49 B | -1.45 B | -1.41 B | -1.38 B | -1.34 B | -1.31 B | - | -1.22 B | -1.18 B | -1.22 B | -1.17 B | -1.11 B | -1.07 B | -1.07 B | -1.07 B | -1.07 B | -873 M | -873 M | -873 M | -873 M | -674 M | -674 M | -674 M | -674 M | -495 M | -495 M | -495 M | -495 M | -366 M | -366 M | -366 M | -366 M | -257 M | -257 M | -257 M | -257 M | -138 M | -138 M | -138 M | -138 M | -62.6 M | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
189 M | 214 M | 204 M | 240 M | 270 M | 298 M | 326 M | 358 M | 231 M | - | 294 M | 305 M | 254 M | 287 M | 275 M | 313 M | 313 M | 313 M | 313 M | 295 M | 295 M | 295 M | 295 M | 341 M | 341 M | 341 M | 341 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 215 M | 215 M | 215 M | 215 M | 220 M | 220 M | 220 M | 220 M | 158 M | 158 M | 158 M | 158 M | 1.31 M | 1.31 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
72.8 M | 84.8 M | 30.6 M | 52.2 M | 43.7 M | 80.9 M | 84.1 M | 135 M | 71.4 M | 82.2 M | 153 M | 190 M | 137 M | 141 M | 88.5 M | 85.9 M | 85.9 M | 85.9 M | 85.9 M | 129 M | 129 M | 129 M | 129 M | 118 M | 118 M | 118 M | 118 M | 69 M | 69 M | 69 M | 69 M | 49.7 M | 49.7 M | 49.7 M | 49.7 M | 58.4 M | 58.4 M | 58.4 M | 58.4 M | 151 M | 151 M | 151 M | 151 M | 156 M | 156 M | 156 M | 156 M | 391 K | 391 K | - | - | 6.51 M | - | - | - |
Book Value |
-160 M | -132 M | -169 M | -136 M | -100 M | -71.2 M | -45.2 M | -16.7 M | -140 M | - | -83.1 M | -79.7 M | -126 M | -83.1 M | -39.6 M | 50.5 M | 50.5 M | 50.5 M | 50.5 M | 49.8 M | 49.8 M | 49.8 M | 49.8 M | 183 M | 183 M | 183 M | 183 M | 129 M | 129 M | 129 M | 129 M | 162 M | 162 M | 162 M | 162 M | 198 M | 198 M | 198 M | 198 M | 207 M | 207 M | 207 M | 207 M | 155 M | 155 M | 155 M | 158 M | 1.31 M | 1.31 M | - | - | - | - | - | - |
Total Shareholders Equity |
-160 M | -132 M | -169 M | -136 M | -100 M | -71.2 M | -45.2 M | -16.7 M | -140 M | -116 M | -83.1 M | -79.7 M | -126 M | -83.1 M | -39.6 M | 50.5 M | 50.5 M | 50.5 M | 50.5 M | 49.8 M | 49.8 M | 49.8 M | 49.8 M | 183 M | 183 M | 183 M | 183 M | 129 M | 129 M | 129 M | 129 M | 162 M | 162 M | 162 M | 162 M | 198 M | 198 M | 198 M | 198 M | 207 M | 207 M | 207 M | 207 M | 155 M | 155 M | 155 M | 155 M | -27.9 M | -27.9 M | - | - | -12.7 M | - | - | - |
All numbers in USD currency